Publication | Closed Access

Characterization of midazolam metabolism using human hepatic musomal fractions and hepatocytes in suspension obtained by perfusing whole human livers

HepatologyWhole Human LiversMedicineLiver PhysiologyHepatotoxicityLiver DiseaseMidazolam MetabolismPharmacologyDrug-induced Liver InjuryPharmacokinetics